Telmisartan+metoprolol+ chlorthalidone contains the active constituents of telmisartan +metoprolol +chlorthalidone, which belong to the antihypertensive drugs which help in controlling high blood pressure and excess water and electrolyte from the body. Telmisartan+metoprolol+ chlorthalidone helps in relaxing the blood vessels by making the heart easier to pump blood all over the body, and it decreases the risk of heart attack and stroke. Telmisartan received FDA approval for the treatment of hypertension on July 21, 1998. Chlorthalidone received FDA approval for the treatment of hypertension on October 16, 1960. Metoprolol received FDA approval on August 18, 1992

Telmisartan+metoprolol+ chlorthalidone is used to treat hypertension.

This medication is taken as per the advice of the doctor. It can be taken on an empty stomach or along with food, but it has to be taken at a fixed time daily. It’s very important to take this medicine even if you feel well. As it causes frequent urination, it's better to have this tablet 4 hrs before going to bed. The dosage of this medication will depend upon the condition and how individuals respond to the medication. Avoid breaking or chewing the tablet. Instead, swallow it whole with a glass of water.

The common side effects of telmisartan, metoprolol, and chlorthalidone may include dizziness, fatigue, headache, low blood pressure, increased urination, electrolyte imbalances (such as low potassium or sodium levels), and gastrointestinal disturbances like nausea or diarrhea. 

These medications carry certain warnings and precautions. They should be used cautiously or avoided in individuals with allergies to any components, severe liver or kidney disease, certain heart conditions, or asthma. Chlorthalidone may increase blood sugar levels and requires caution in individuals with diabetes. 

These medications can also interact with other drugs, so you must inform your healthcare provider about all the medications you are taking. Regular monitoring of blood pressure, electrolyte levels, and kidney and liver function may be necessary during treatment. It is recommended to consult with a healthcare professional for personalized guidance and to ensure safe and appropriate use of these medications.

It is suggested to tell your doctor if you have any history of allergic reactions to avoid life-threatening complications. Tell the doctor before the treatment commencement if the patient is pregnant or having liver, kidney, or uterine problems and other medicines taken for hypertension and a heart condition. While using this medication, blood pressure, liver, and diabetes should be monitored regularly, and a kidney function test should be performed to note if there are any abnormal changes.

1. KD. Tripathi. Antianginal and Other Anti-ischaemic Drugs & Drugs Affecting Renin-Angiotensin System. Eighth edition. June 2018. Page – 596 & 536.
2. https://www.medicines.org.uk/emc/files/pil.9981.pdf [Revised on November 2019] [Accessed on 26/06/2023]
3. https://go.drugbank.com/drugs/DB00310 [Revised on 8/11/2022) [Accessed on 26/06/2023]

The drug information on this page is different from medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.